With 10.11 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.94 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.33 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $4.33. Beta for the stock currently stands at 0.80.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AKBA was up-trending over the past week, with a rise of 9.29%, but this was up by 32.45% over a month. Three-month performance surged to 68.07% while six-month performance rose 76.99%. The stock gained 213.09% in the past year, while it has gained 61.29% so far this year. A look at the trailing 12-month EPS for AKBA yields -0.28 with Next year EPS estimates of -0.23. For the next quarter, that number is -0.09. This implies an EPS growth rate of 7.89% for this year and 10.91% for next year.
Float and Shares Shorts:
At present, 194.58 million AKBA shares are outstanding with a float of 184.15 million shares on hand for trading. On Feb 29, 2024, short shares totaled 8.11 million, which was 4.31% higher than short shares on Jan 31, 2024. In addition to AKBA as the firm’s Akebia Therapeutics, Inc., AMBA serves as its Ambarella, Inc.
Institutional Ownership:
Through their ownership of 26.28% of AKBA’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AKBA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, AKBA has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and AKBA currently yields $0.00. In the past year, AKBA’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, AKBA has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.
